• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与多发性硬化症的关系:2010 年至 2023 年的科学计量可视化分析。

Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023.

机构信息

Department of Neurology, Suining Central Hospital, Suining, China.

Department of Emergency, Suining Central Hospital, Suining, China.

出版信息

Front Immunol. 2024 Aug 19;15:1451742. doi: 10.3389/fimmu.2024.1451742. eCollection 2024.

DOI:10.3389/fimmu.2024.1451742
PMID:39224586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11366631/
Abstract

BACKGROUND

Numerous studies have investigated the relationship between gut microbiota (GM) and multiple sclerosis(MS), highlighting the significant role of GM in MS. However, there is a lack of systematic Scientometric analyses published in this specific research area to provide an overall understanding of the current research status.

METHODS

Perform a scientometric analysis on research conducted between 2010 and 2023 concerning the link between GM and MS using quantitative and visual analysis software (CiteSpace and VOSviewer.).

RESULTS

From January 1, 2010, and December 31, 2023, a total of 1019 records about GM and MS were retrieved. The number of publications exhibited a consistent upward trend annually. The United States led in publications, showed the strongest level of collaboration among countries. The University of California, San Francisco stands as the top institution in terms of output, and the most prolific and cited authors were Lloyd H. Kasper and Javier Ochoa-Reparaz from the USA. The research in this field primarily centers on investigating the alterations and associations of GM in MS or EAE, the molecular immunological mechanisms, and the potential of GM-based interventions to provide beneficial effects in MS or EAE. The Keywords co-occurrence network reveals five primary research directions in this field. The most frequently occurring keywords are inflammation, probiotics, diet, dysbiosis, and tryptophan. In recent years, neurodegeneration and neuropsychiatric disorders have been prominent, indicating that the investigation of the mechanisms and practical applications of GM in MS has emerged as a current research focus. Moreover, GM research is progressively extending into the realm of neurodegenerative and psychiatric diseases, potentially becoming future research hotspots.

CONCLUSIONS

This study revealed a data-driven systematic comprehension of research in the field of GM in MS over the past 13 years, highlighted noteworthy research within the field, provided us with a clear understanding of the current research status and future trends, providing a valuable reference for researchers venturing into this domain.

摘要

背景

大量研究探讨了肠道微生物群(GM)与多发性硬化症(MS)之间的关系,突出了 GM 在 MS 中的重要作用。然而,在这一特定研究领域,缺乏系统的科学计量学分析,无法全面了解当前的研究现状。

方法

使用定量和可视化分析软件(CiteSpace 和 VOSviewer)对 2010 年至 2023 年间 GM 与 MS 之间关联的研究进行科学计量学分析。

结果

从 2010 年 1 月 1 日至 2023 年 12 月 31 日,共检索到 1019 篇关于 GM 和 MS 的记录。出版物数量呈逐年持续上升趋势。美国在出版物方面处于领先地位,各国之间的合作水平最强。在产出方面,加州大学旧金山分校位居榜首,最具影响力和引用量的作者是美国的 Lloyd H. Kasper 和 Javier Ochoa-Reparaz。该领域的研究主要集中在研究 MS 或 EAE 中 GM 的变化和关联、分子免疫学机制,以及 GM 干预在 MS 或 EAE 中提供有益效果的潜力。关键词共现网络揭示了该领域的五个主要研究方向。出现频率最高的关键词是炎症、益生菌、饮食、生态失调和色氨酸。近年来,神经退行性变和神经精神疾病成为突出问题,表明 GM 在 MS 中的机制和实际应用的研究已成为当前的研究重点。此外,GM 研究正在逐步扩展到神经退行性和精神疾病领域,可能成为未来的研究热点。

结论

本研究揭示了过去 13 年中 GM 与 MS 领域研究的基于数据的系统理解,突出了该领域的重要研究,使我们清楚地了解了当前的研究现状和未来趋势,为涉足该领域的研究人员提供了有价值的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/7274f85fa910/fimmu-15-1451742-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/516370db28b5/fimmu-15-1451742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/2de44c68f906/fimmu-15-1451742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/dc6c119e0cc1/fimmu-15-1451742-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/5898b05fbec6/fimmu-15-1451742-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/7678ab04ad6d/fimmu-15-1451742-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/415c25a43060/fimmu-15-1451742-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/4f235db45581/fimmu-15-1451742-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/9be527d2ccab/fimmu-15-1451742-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/16c7f1177987/fimmu-15-1451742-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/8edf5ef343d4/fimmu-15-1451742-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/7274f85fa910/fimmu-15-1451742-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/516370db28b5/fimmu-15-1451742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/2de44c68f906/fimmu-15-1451742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/dc6c119e0cc1/fimmu-15-1451742-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/5898b05fbec6/fimmu-15-1451742-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/7678ab04ad6d/fimmu-15-1451742-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/415c25a43060/fimmu-15-1451742-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/4f235db45581/fimmu-15-1451742-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/9be527d2ccab/fimmu-15-1451742-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/16c7f1177987/fimmu-15-1451742-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/8edf5ef343d4/fimmu-15-1451742-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f07/11366631/7274f85fa910/fimmu-15-1451742-g011.jpg

相似文献

1
Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023.肠道微生物群与多发性硬化症的关系:2010 年至 2023 年的科学计量可视化分析。
Front Immunol. 2024 Aug 19;15:1451742. doi: 10.3389/fimmu.2024.1451742. eCollection 2024.
2
Visual analysis of colorectal cancer and gut microbiota: A bibliometric analysis from 2002 to 2022.结直肠癌与肠道微生物群的可视化分析:2002 年至 2022 年的文献计量学分析。
Medicine (Baltimore). 2023 Nov 3;102(44):e35727. doi: 10.1097/MD.0000000000035727.
3
Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis.肠道微生物群与结直肠癌关系的研究趋势:文献计量分析。
Front Cell Infect Microbiol. 2023 Jan 9;12:1027448. doi: 10.3389/fcimb.2022.1027448. eCollection 2022.
4
Global research trends in regulating gut microbiome to improve type 2 diabetes mellitus: bibliometrics and visual analysis.调控肠道微生物组改善 2 型糖尿病的全球研究趋势:文献计量学和可视化分析。
Front Endocrinol (Lausanne). 2024 Jun 3;15:1401070. doi: 10.3389/fendo.2024.1401070. eCollection 2024.
5
Trends and hotspots on the relationship between gut microbiota and Parkinson's Disease: a bibliometric analysis.肠道微生物群与帕金森病关系的研究趋势和热点:文献计量分析。
Front Cell Infect Microbiol. 2024 Sep 30;14:1421270. doi: 10.3389/fcimb.2024.1421270. eCollection 2024.
6
Emerging trends and hotspots in the links between the gut microbiota and MAFLD from 2002 to 2021: A bibliometric analysis.2002 年至 2021 年肠道微生物群与 MAFLD 之间关联的新兴趋势和热点:文献计量分析。
Front Endocrinol (Lausanne). 2022 Oct 13;13:990953. doi: 10.3389/fendo.2022.990953. eCollection 2022.
7
Gut microbiota and eye diseases: a bibliometric study and visualization analysis.肠道微生物群与眼部疾病:文献计量学研究与可视化分析。
Front Cell Infect Microbiol. 2023 Aug 9;13:1225859. doi: 10.3389/fcimb.2023.1225859. eCollection 2023.
8
Relationship between gut microbiota and rheumatoid arthritis: A bibliometric analysis.肠道微生物群与类风湿关节炎的关系:文献计量分析。
Front Immunol. 2023 Mar 1;14:1131933. doi: 10.3389/fimmu.2023.1131933. eCollection 2023.
9
Bibliometric and visual analysis of intestinal flora and immunity.肠道菌群与免疫的文献计量学和可视化分析
Medicine (Baltimore). 2024 Jan 26;103(4):e36575. doi: 10.1097/MD.0000000000036575.
10
Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021).全球关于肠道微生物群与癌症免疫治疗关联的研究趋势:文献计量分析(2012-2021 年)。
Front Immunol. 2022 Aug 24;13:952546. doi: 10.3389/fimmu.2022.952546. eCollection 2022.

引用本文的文献

1
The hidden genetic and microbial networks connecting neuropsychiatric and digestive disorders.连接神经精神疾病和消化系统疾病的隐藏遗传与微生物网络。
Comput Struct Biotechnol J. 2025 Jul 16;27:3114-3126. doi: 10.1016/j.csbj.2025.07.029. eCollection 2025.
2
Global research trends in the relationship between diabetic cardiomyopathy and mitochondria: a bibliometric analysis.糖尿病性心肌病与线粒体关系的全球研究趋势:一项文献计量分析
Hereditas. 2025 Jul 1;162(1):114. doi: 10.1186/s41065-025-00488-3.
3
An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies.

本文引用的文献

1
The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.短链脂肪酸在多发性硬化症中的免疫调节潜力。
Int J Mol Sci. 2024 Mar 11;25(6):3198. doi: 10.3390/ijms25063198.
2
Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis.多发性硬化症外周免疫细胞的线粒体和代谢功能障碍。
J Neuroinflammation. 2024 Jan 20;21(1):28. doi: 10.1186/s12974-024-03016-8.
3
Gut flora in multiple sclerosis: implications for pathogenesis and treatment.多发性硬化症中的肠道菌群:对发病机制和治疗的影响。
一项探索神经退行性疾病和神经创伤中肠-脑轴的最新综合综述:对治疗策略的启示
Brain Sci. 2025 Jun 18;15(6):654. doi: 10.3390/brainsci15060654.
4
Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?产气荚膜梭菌ε毒素是否模拟了一种参与多发性硬化症的自身抗原?
Toxins (Basel). 2025 Jan 7;17(1):27. doi: 10.3390/toxins17010027.
5
Influential articles in autism and gut microbiota: bibliometric profile and research trends.自闭症与肠道微生物群领域的影响力文章:文献计量分析及研究趋势
Front Microbiol. 2025 Jan 9;15:1401597. doi: 10.3389/fmicb.2024.1401597. eCollection 2024.
Neural Regen Res. 2024 Jul 1;19(7):1480-1488. doi: 10.4103/1673-5374.387974. Epub 2023 Nov 13.
4
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.靶向肠道菌群:多发性硬化症的新治疗机会。
Gut Microbes. 2023 Dec;15(2):2274126. doi: 10.1080/19490976.2023.2274126. Epub 2023 Nov 18.
5
Multiple sclerosis.多发性硬化症。
Lancet. 2024 Jan 13;403(10422):183-202. doi: 10.1016/S0140-6736(23)01473-3. Epub 2023 Nov 7.
6
The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders.肠道微生物组在多发性硬化症及相关疾病发病机制中的作用。
Cells. 2023 Jun 30;12(13):1760. doi: 10.3390/cells12131760.
7
H generated by fermentation in the human gut microbiome influences metabolism and competitive fitness of gut butyrate producers.人类肠道微生物组发酵产生的 H 会影响肠道丁酸盐产生菌的代谢和竞争适应性。
Microbiome. 2023 Jun 15;11(1):133. doi: 10.1186/s40168-023-01565-3.
8
Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives.肠道微生物组与多发性硬化症:背景、证据和展望。
Nutrients. 2023 Feb 14;15(4):942. doi: 10.3390/nu15040942.
9
The gut microbiota in multiple sclerosis varies with disease activity.多发性硬化症患者的肠道微生物群与疾病活动度有关。
Genome Med. 2023 Jan 5;15(1):1. doi: 10.1186/s13073-022-01148-1.
10
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.从微生物群中挖掘可调节多发性硬化症小鼠模型神经炎症的肠道共生菌。
Microbiome. 2022 Oct 17;10(1):174. doi: 10.1186/s40168-022-01364-2.